Literature DB >> 7558301

Recognition of three epitopic regions on invasion plasmid antigen C by immune sera of rhesus monkeys infected with Shigella flexneri 2a.

K R Turbyfill1, S W Joseph, E V Oaks.   

Abstract

The invasive ability of Shigella spp. is correlated with the expression of several plasmid-encoded proteins, including invasion plasmid antigen C (IpaC). By characterizing the antigenic structure of IpaC with monoclonal antibodies and convalescent-phase sera, it may be possible to determine the physical location of specific epitopes as well as the involvement of epitopes in a protective immune response or the host's susceptibility to disease. By using overlapping octameric synthetic peptides, which together represent the entire IpaC protein, the precise linear sequence of four surface-exposed epitopes was defined for four IpaC monoclonal antibodies. Furthermore, 17 unique peptide epitopes of IpaC were mapped by using 9-day-postinfection serum samples from 13 rhesus monkeys challenged with Shigella flexneri 2a. Each individual recognized a somewhat different array of IpaC peptide epitopes after infection with shigellae. However, the epitopes were clustered within three regions of the protein: region I (between amino acid residues 1 and 61), region II (between amino acid residues 177 and 258), and region III (between amino acid residues 298 and 307). Region II was recognized by 92% of S. flexneri-infected individuals and was considered to be a highly immunogenic region. Animals asymptomatic for shigellosis after challenge with S. flexneri recognized peptide epitopes within all three epitopic regions of IpaC, whereas symptomatic animals recognized peptides in only one or two of the epitopic regions. Antibody from monkeys challenged with S. sonnei recognized IpaC peptide epitopes which fell within and outside the three S. flexneri epitopic regions. While numerous potential epitopes exist on the IpaC protein, the identification of three regions in which epitopes are clustered suggests that these regions are significant with respect to the immune response and to subsequent pathogenesis postinfection.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7558301      PMCID: PMC173552          DOI: 10.1128/iai.63.10.3927-3935.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  Studies in shigellosis. III. A controlled evaluation of a monovalent Shigella vaccine in a highly endemic environment.

Authors:  A R HIGGINS; T M FLOYD; M A KADER
Journal:  Am J Trop Med Hyg       Date:  1955-03       Impact factor: 2.345

2.  Characterization of invasion plasmid antigen genes (ipaBCD) from Shigella flexneri.

Authors:  M M Venkatesan; J M Buysse; D J Kopecko
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

3.  Localization of plasmid loci necessary for the entry of Shigella flexneri into HeLa cells, and characterization of one locus encoding four immunogenic polypeptides.

Authors:  B Baudry; A T Maurelli; P Clerc; J C Sadoff; P J Sansonetti
Journal:  J Gen Microbiol       Date:  1987-12

4.  Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid.

Authors:  H M Geysen; R H Meloen; S J Barteling
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

5.  The 56-kilodalton major protein antigen of Rickettsia tsutsugamushi: molecular cloning and sequence analysis of the sta56 gene and precise identification of a strain-specific epitope.

Authors:  C K Stover; D P Marana; J M Carter; B A Roe; E Mardis; E V Oaks
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

6.  Efficacy of bovine milk immunoglobulin concentrate in preventing illness after Shigella flexneri challenge.

Authors:  C O Tacket; S B Binion; E Bostwick; G Losonsky; M J Roy; R Edelman
Journal:  Am J Trop Med Hyg       Date:  1992-09       Impact factor: 2.345

7.  Nucleotide sequence of the ipaBCD structural genes of Shigella dysenteriae.

Authors:  R Yao; S Palchaudhuri
Journal:  Mol Microbiol       Date:  1991-09       Impact factor: 3.501

8.  Identification and characterization of B-cell epitopes of IpaC, an invasion-associated protein of Shigella flexneri.

Authors:  A Phalipon; J Arondel; F Nato; S Rouyre; J C Mazie; P J Sansonetti
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

9.  Molecular cloning of invasion plasmid antigen (ipa) genes from Shigella flexneri: analysis of ipa gene products and genetic mapping.

Authors:  J M Buysse; C K Stover; E V Oaks; M Venkatesan; D J Kopecko
Journal:  J Bacteriol       Date:  1987-06       Impact factor: 3.490

10.  Shigella flexneri invasion plasmid antigens B and C: epitope location and characterization with monoclonal antibodies.

Authors:  J A Mills; J M Buysse; E V Oaks
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

View more
  9 in total

1.  Soluble invasion plasmid antigen C (IpaC) from Shigella flexneri elicits epithelial cell responses related to pathogen invasion.

Authors:  M E Marquart; W L Picking; W D Picking
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

2.  Identification of epitope and surface-exposed domains of Shigella flexneri invasion plasmid antigen D (IpaD).

Authors:  K R Turbyfill; J A Mertz; C P Mallett; E V Oaks
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

3.  IpaD of Shigella flexneri is independently required for regulation of Ipa protein secretion and efficient insertion of IpaB and IpaC into host membranes.

Authors:  Wendy L Picking; Hiroaki Nishioka; Patricia D Hearn; M Aaron Baxter; Amanda T Harrington; Ariel Blocker; William D Picking
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

4.  Antibody response of monkeys to invasion plasmid antigen D after infection with Shigella spp.

Authors:  E V Oaks; W D Picking; W L Picking
Journal:  Clin Diagn Lab Immunol       Date:  1996-03

5.  Isolation and characterization of a Shigella flexneri invasin complex subunit vaccine.

Authors:  K R Turbyfill; A B Hartman; E V Oaks
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

6.  Structural characterization of the N terminus of IpaC from Shigella flexneri.

Authors:  Amanda T Harrington; Patricia D Hearn; Wendy L Picking; Jeffrey R Barker; Andrew Wessel; William D Picking
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

7.  Immunogenicity of IpaC-hybrid proteins expressed in the Shigella flexneri 2a vaccine candidate SC602.

Authors:  S Bârzu; J Arondel; S Guillot; P J Sansonetti; A Phalipon
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

8.  TonB is required for intracellular growth and virulence of Shigella dysenteriae.

Authors:  S A Reeves; A G Torres; S M Payne
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

9.  Assembly, Biochemical Characterization, Immunogenicity, Adjuvanticity, and Efficacy of Shigella Artificial Invaplex.

Authors:  K Ross Turbyfill; Kristen A Clarkson; Anthony R Vortherms; Edwin V Oaks; Robert W Kaminski
Journal:  mSphere       Date:  2018-03-28       Impact factor: 4.389

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.